Skip to main content

D07.1 vs Z85.828

D07.1 (Carcinoma in situ of vulva) compared with Z85.828 (Personal history of other malignant neoplasm of skin), from the official CMS tabular data. Z85.828 is the personal-history/screening code for the active disease D07.1 names. MedCoder-derived

Relationship

Review

Condition lifecycle relationship

Z85.828
Personal history of other malignant neoplasm of skin
D07.1
Carcinoma in situ of vulva

Personal-history or screening code versus the active disease.

In-situ disease for this site (skin)

A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code for the same site.

Source: CMS Table of Neoplasms (site match derived from the code title)

Can these codes be reported together?

History or screening versus active disease. Z85.828 is the personal-history or screening code for the active disease D07.1 names.

Site match derived from the code’s own title against the CMS/CDC Table of Neoplasms. A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code.

Side by side

D07.1Carcinoma in situ of vulvaZ85.828Personal history of other malignant neoplasm of skin
Billing statusBillableBillable
ClassificationC00-D49 — Neoplasms (C00-D49)Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)
DefinitionCarcinoma in situ of vulva is a billable ICD-10-CM diagnosis code (D07.1).Personal history of other malignant neoplasm of skin is a billable ICD-10-CM diagnosis code (Z85.828).
Includes
Bowen's disease
erythroplasia
grade III intraepithelial neoplasia
Queyrat's erythroplasia
Conditions classifiable to C44
Use additional code
code to identify:
alcohol use and dependence (F10.-)
exposure to environmental tobacco smoke (Z77.22)
Code first
any follow-up examination after treatment of malignant neoplasm (Z08)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources